Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 335
Immune Disorders Drugs 207
Biopharmaceuticals 175
Musculoskeletal Disorders Drugs 125
Genomics 116
Cardiovascular Drugs 104
Biotechnology 84
Pharmaceuticals 80
Drug Discovery 77
Endocrine and Metabolic Disorders Drugs 76
Biosimilars and Biosuperiors 72
Allergy and Immunology 67
Infusions and Injectables 65
Leukemia Drugs 63
Hematological Drugs 60
Clinical Trials 53
Oncology 52
Dermatological Drugs 51
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 45
Women's Health 44
Needles and Syringes 42
Drug Delivery 38
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 30
Infectious Diseases Drugs 28
Brain Cancer Drugs 28
Enzymes 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Proteomics 26
Gastrointestinal Drugs 26
Analgesics 24
Immunosuppressive Drugs 24
Lymphoma Drugs 23
Dermatology 19
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Optical 17
Therapeutic Area 16
Respiratory Drugs 16
Urology and Nephrology 15
Healthcare Services 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Biomarkers 7
Anti-Obesity Drugs 7
Gastroenterology 7
Neurology 6
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Company Reports 5
Animal Pharmaceuticals 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

2,083 Results (Page 17 of 105)
- Relevance
  Sort by

Alopecia Treatment - Global Strategic Business Report

 Report
March 2026
287 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Immunotoxins - Global Strategic Business Report

 Report
March 2026
377 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035

 Report
March 2025
1048 Pages
Global

From

€4296EUR$4,799USD£3,752GBP

Non-Opioid Therapeutics Market - Global Forecast 2025-2032

 Report
November 2025
197 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Chemotherapy-Induced Neutropenia (CIN) Treatment Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

 Report
August 2022
113 Pages
Global

From

€4252EUR$4,750USD£3,714GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Type 2 Diabetes Market 2025-2029

 Report
February 2025
221 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

Non-Infectious Macular Edema Treatment - Global Strategic Business Report

 Report
March 2026
196 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
628 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
820 Pages
Global

From

€1790EUR$2,000USD£1,564GBP

Irritable Bowel Syndrome (IBS) Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Generic Musculoskeletal Disorders Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Intestinal Pseudo-Obstruction Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Gastroesophageal Reflux Disease (GERD) Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Acute Pancreatitis Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Kidney Disease Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Chronic Kidney Disease Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Thyroid Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031

 Drug Pipelines
February 2026
3300 Pages
United States

From

€8056EUR$9,000USD£7,037GBP

Graves' Disease (Overactive Thyroid) Market - Global Strategic Business Report

 Report
March 2026
386 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Acute Ischemic Stroke Therapeutics Market 2026-2030

 Report
January 2026
291 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

2,083 Results (Page 17 of 105)
- 1
- 15
- 16
- 17
- 18
- 19

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.